Compare ETB & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund of Beneficial Interest
Current Price
| Metric | ETB | AVNS |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.8M | 521.7M |
| IPO Year | N/A | N/A |
| Metric | ETB | AVNS |
|---|---|---|
| Price | $15.41 | $13.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 71.8K | ★ 582.6K |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | ★ 8.23% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $2.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $11.59 | $9.30 |
| 52 Week High | $14.08 | $17.69 |
| Indicator | ETB | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 68.41 |
| Support Level | $15.31 | $12.75 |
| Resistance Level | $15.58 | $13.28 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 77.39 | 95.77 |
Eaton Vance Tax-Managed Buy-Write Income Fund is a United States-based diversified closed ended management investment company. The fund's investment objective is to provide current income and gains, with a secondary objective of capital appreciation. It invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of aerospace and defense, banks, biotechnology, chemicals, consumer finance, industrial conglomerates, and others.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.